Action Levels for Lead in Processed Food Intended for Babies and Young Children; Guidance for Industry; Availability, 1135-1136 [2024-31534]
Download as PDF
Federal Register / Vol. 90, No. 4 / Tuesday, January 7, 2025 / Notices
revises the list of tree nuts that FDA
considers as major food allergens.
We also have revised several
questions and answers to update and
clarify information presented in
previous editions, including questions
related to the labeling of fish and
Crustacean shellfish.
II. Paperwork Reduction Act of 1995
This guidance contains information
collection provisions that are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501–
3521). The collections of information in
section 403(w) of the FD&C Act (21
U.S.C. 343(w)) have been approved
under OMB control number 0910–0792.
III. Electronic Access
Persons with access to the internet
may obtain the guidance document at
https://www.fda.gov/regulatoryinformation/search-fda-guidancedocuments, https://www.fda.gov/
FoodGuidances, or https://
www.regulations.gov. Use the FDA
website listed in the previous sentence
to find the most current version of the
guidance.
Dated: December 27, 2024.
Kimberlee Trzeciak,
Deputy Commissioner for Policy, Legislation,
and International Affairs.
[FR Doc. 2024–31533 Filed 1–6–25; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2022–D–0278]
Action Levels for Lead in Processed
Food Intended for Babies and Young
Children; Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or we) is
announcing the availability of a final
guidance for industry entitled ‘‘Action
Levels for Lead in Processed Food
Intended for Babies and Young
Children.’’ The guidance establishes
action levels for lead in certain
processed foods intended for babies and
young children less than 2 years old.
The guidance is intended to set
achievable action levels that will help
further reduce lead in the food supply.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:44 Jan 06, 2025
Jkt 265001
The announcement of the
guidance is published in the Federal
Register on January 7, 2025.
ADDRESSES: You may submit either
electronic or written comments on FDA
guidances at any time as follows:
DATES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2022–D–0278 for ‘‘Action Levels for
Lead in Processed Food Intended for
Babies and Young Children; Guidance
for Industry.’’ Received comments will
be placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
1135
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ We
will review this copy, including the
claimed confidential information, in our
consideration of comments. The second
copy, which will have the claimed
confidential information redacted/
blacked out, will be available for public
viewing and posted on https://
www.regulations.gov. Submit both
copies to the Dockets Management Staff.
If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of the guidance to the Office of
Food Chemical Safety, Dietary
Supplements, and Innovation, Human
Foods Program, Food and Drug
Administration, 5001 Campus Dr.,
College Park, MD 20740. Send two selfaddressed adhesive labels to assist that
office in processing your request. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the guidance.
FOR FURTHER INFORMATION CONTACT:
Eileen Abt, Office of Food Chemical
Safety, Dietary Supplements, and
Innovation, Human Foods Program,
Food and Drug Administration, 5001
Campus Dr., College Park, MD 20740,
240–402–1700; or Holli Kubicki, Office
of Policy, Regulations, and Information,
Human Foods Program, Food and Drug
E:\FR\FM\07JAN1.SGM
07JAN1
1136
Federal Register / Vol. 90, No. 4 / Tuesday, January 7, 2025 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–2378.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the availability of
a guidance for industry entitled ‘‘Action
Levels for Lead in Processed Food
Intended for Babies and Young
Children.’’ We are issuing this guidance
consistent with our good guidance
practices regulation (21 CFR 10.115).
The guidance represents the current
thinking of FDA on this topic. It does
not establish any rights for any person
and is not binding on FDA or the public.
You can use an alternative approach if
it satisfies the requirements of the
applicable statutes and regulations.
In the Federal Register of January 25,
2023 (88 FR 4749), we made available
a draft guidance for industry entitled
‘‘Action Levels for Lead in Food
Intended for Babies and Young
Children’’ and gave interested parties an
opportunity to submit comments by
March 27, 2023, for us to consider
before beginning work on the final
version of the guidance. In the Federal
Register of April 6, 2023 (88 FR 20525),
we announced that we were reopening
the comment period until May 8, 2023,
to allow interested parties additional
time to submit comments. We received
several comments on the draft guidance
and have modified the final guidance
where appropriate. Changes to the
guidance include clarifications to the
foods that the guidance addresses,
including the age range of the foods’
intended consumers. We added
information about the method that FDA
uses to test for lead in food and made
several editorial changes to improve
clarity of the guidance. We also
collected and analyzed additional
samples from our Toxic Elements
Program and special FDA surveys to
inform our exposure and achievability
assessments. The guidance announced
in this notice finalizes the draft
guidance dated January 2023.
In accordance with § 109.6 (21 CFR
109.6), this guidance establishes the
following action levels for lead in
processed food intended for babies and
young children less than 2 years old: 10
parts per billion (ppb) for fruits,
vegetables (excluding single-ingredient
root vegetables), mixtures (including
grain- and meat-based mixtures),
yogurts, custards/puddings, and singleingredient meats; 20 ppb for singleingredient root vegetables; and 20 ppb
for dry infant cereals. Consistent with
§ 109.6(d), these action levels reflect
levels of lead at which FDA may regard
the food as adulterated within the
meaning of section 402(a)(1) of the
VerDate Sep<11>2014
18:44 Jan 06, 2025
Jkt 265001
Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 342(a)(1)). We intend to
consider these action levels, in addition
to other factors, when considering
whether to bring enforcement action in
a particular case.
II. Paperwork Reduction Act of 1995
This guidance contains no collection
of information. Therefore, clearance by
the Office of Management and Budget
under the Paperwork Reduction Act of
1995 is not required.
III. Electronic Access
Persons with access to the internet
may obtain the guidance at https://
www.fda.gov/FoodGuidances, https://
www.fda.gov/regulatory-information/
search-fda-guidance-documents, or
https://www.regulations.gov. Use the
FDA website listed in the previous
sentence to find the most current
version of the guidance.
Dated: December 27, 2024.
Kimberlee Trzeciak,
Deputy Commissioner for Policy, Legislation,
and International Affairs.
[FR Doc. 2024–31534 Filed 1–6–25; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–D–3517]
Interim Policy on Compounding Using
Bulk Drug Substances Under Section
503A of the Federal Food, Drug, and
Cosmetic Act; Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a final
guidance for industry entitled ‘‘Interim
Policy on Compounding Using Bulk
Drug Substances Under Section 503A of
the Federal Food, Drug, and Cosmetic
Act.’’ This guidance describes FDA’s
interim policy concerning compounding
by human drug product compounders
that are not outsourcing facilities using
bulk drug substances while FDA
develops the list of bulk drug substances
that can be used in compounding under
the applicable section of the Federal
Food, Drug, and Cosmetic Act (FD&C
Act). This guidance finalizes the draft
guidance of the same title issued in
December 2023 and replaces the final
guidance of the same title issued in
January 2017.
SUMMARY:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
The announcement of the
guidance is published in the Federal
Register on January 7, 2025.
ADDRESSES: You may submit either
electronic or written comments on
Agency guidances at any time as
follows:
DATES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2015–D–3517 for ‘‘Interim Policy on
Compounding Using Bulk Drug
Substances Under Section 503A of the
Federal Food, Drug, and Cosmetic Act.’’
Received comments will be placed in
the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
E:\FR\FM\07JAN1.SGM
07JAN1
Agencies
[Federal Register Volume 90, Number 4 (Tuesday, January 7, 2025)]
[Notices]
[Pages 1135-1136]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-31534]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2022-D-0278]
Action Levels for Lead in Processed Food Intended for Babies and
Young Children; Guidance for Industry; Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of availability.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing the
availability of a final guidance for industry entitled ``Action Levels
for Lead in Processed Food Intended for Babies and Young Children.''
The guidance establishes action levels for lead in certain processed
foods intended for babies and young children less than 2 years old. The
guidance is intended to set achievable action levels that will help
further reduce lead in the food supply.
DATES: The announcement of the guidance is published in the Federal
Register on January 7, 2025.
ADDRESSES: You may submit either electronic or written comments on FDA
guidances at any time as follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2022-D-0278 for ``Action Levels for Lead in Processed Food Intended
for Babies and Young Children; Guidance for Industry.'' Received
comments will be placed in the docket and, except for those submitted
as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday, 240-402-7500.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' We will review
this copy, including the claimed confidential information, in our
consideration of comments. The second copy, which will have the claimed
confidential information redacted/blacked out, will be available for
public viewing and posted on https://www.regulations.gov. Submit both
copies to the Dockets Management Staff. If you do not wish your name
and contact information to be made publicly available, you can provide
this information on the cover sheet and not in the body of your
comments and you must identify this information as ``confidential.''
Any information marked as ``confidential'' will not be disclosed except
in accordance with 21 CFR 10.20 and other applicable disclosure law.
For more information about FDA's posting of comments to public dockets,
see 80 FR 56469, September 18, 2015, or access the information at:
https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
You may submit comments on any guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single copies of the guidance to the
Office of Food Chemical Safety, Dietary Supplements, and Innovation,
Human Foods Program, Food and Drug Administration, 5001 Campus Dr.,
College Park, MD 20740. Send two self-addressed adhesive labels to
assist that office in processing your request. See the SUPPLEMENTARY
INFORMATION section for electronic access to the guidance.
FOR FURTHER INFORMATION CONTACT: Eileen Abt, Office of Food Chemical
Safety, Dietary Supplements, and Innovation, Human Foods Program, Food
and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240-
402-1700; or Holli Kubicki, Office of Policy, Regulations, and
Information, Human Foods Program, Food and Drug
[[Page 1136]]
Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-2378.
SUPPLEMENTARY INFORMATION:
I. Background
We are announcing the availability of a guidance for industry
entitled ``Action Levels for Lead in Processed Food Intended for Babies
and Young Children.'' We are issuing this guidance consistent with our
good guidance practices regulation (21 CFR 10.115). The guidance
represents the current thinking of FDA on this topic. It does not
establish any rights for any person and is not binding on FDA or the
public. You can use an alternative approach if it satisfies the
requirements of the applicable statutes and regulations.
In the Federal Register of January 25, 2023 (88 FR 4749), we made
available a draft guidance for industry entitled ``Action Levels for
Lead in Food Intended for Babies and Young Children'' and gave
interested parties an opportunity to submit comments by March 27, 2023,
for us to consider before beginning work on the final version of the
guidance. In the Federal Register of April 6, 2023 (88 FR 20525), we
announced that we were reopening the comment period until May 8, 2023,
to allow interested parties additional time to submit comments. We
received several comments on the draft guidance and have modified the
final guidance where appropriate. Changes to the guidance include
clarifications to the foods that the guidance addresses, including the
age range of the foods' intended consumers. We added information about
the method that FDA uses to test for lead in food and made several
editorial changes to improve clarity of the guidance. We also collected
and analyzed additional samples from our Toxic Elements Program and
special FDA surveys to inform our exposure and achievability
assessments. The guidance announced in this notice finalizes the draft
guidance dated January 2023.
In accordance with Sec. 109.6 (21 CFR 109.6), this guidance
establishes the following action levels for lead in processed food
intended for babies and young children less than 2 years old: 10 parts
per billion (ppb) for fruits, vegetables (excluding single-ingredient
root vegetables), mixtures (including grain- and meat-based mixtures),
yogurts, custards/puddings, and single-ingredient meats; 20 ppb for
single-ingredient root vegetables; and 20 ppb for dry infant cereals.
Consistent with Sec. 109.6(d), these action levels reflect levels of
lead at which FDA may regard the food as adulterated within the meaning
of section 402(a)(1) of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 342(a)(1)). We intend to consider these action levels, in
addition to other factors, when considering whether to bring
enforcement action in a particular case.
II. Paperwork Reduction Act of 1995
This guidance contains no collection of information. Therefore,
clearance by the Office of Management and Budget under the Paperwork
Reduction Act of 1995 is not required.
III. Electronic Access
Persons with access to the internet may obtain the guidance at
https://www.fda.gov/FoodGuidances, https://www.fda.gov/regulatory-information/search-fda-guidance-documents, or https://www.regulations.gov. Use the FDA website listed in the previous
sentence to find the most current version of the guidance.
Dated: December 27, 2024.
Kimberlee Trzeciak,
Deputy Commissioner for Policy, Legislation, and International Affairs.
[FR Doc. 2024-31534 Filed 1-6-25; 8:45 am]
BILLING CODE 4164-01-P